Jane Street Group, LLC Werewolf Therapeutics, Inc. Transaction History
Jane Street Group, LLC
- $481 Billion
- Q2 2025
A detailed history of Jane Street Group, LLC transactions in Werewolf Therapeutics, Inc. stock. As of the latest transaction made, Jane Street Group, LLC holds 374,939 shares of HOWL stock, worth $449,926. This represents 0.0% of its overall portfolio holdings.
Number of Shares
374,939Holding current value
$449,926% of portfolio
0.0%Shares
7 transactions
Others Institutions Holding HOWL
# of Institutions
66Shares Held
23.6MCall Options Held
0Put Options Held
0-
Ra Capital Management, L.P. Boston, MA6.68MShares$8.02 Million0.16% of portfolio
-
Mpm Asset Management LLC Cambridge, MA4.31MShares$5.17 Million10.84% of portfolio
-
Bio Impact Capital LLC Cambridge, MA2.41MShares$2.89 Million0.51% of portfolio
-
Bank Of America Corp Charlotte, NC2.13MShares$2.55 Million0.0% of portfolio
-
Black Rock Inc. New York, NY1.59MShares$1.91 Million0.0% of portfolio
About Werewolf Therapeutics, Inc.
- Ticker HOWL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 29,529,400
- Market Cap $35.4M
- Description
- Werewolf Therapeutics, Inc., a biopharmaceutical company, develops therapeutics engineered to stimulate the body's immune system for the treatment of cancer. The company, through its proprietary PREDATOR platform, designs conditionally activated molecules that stimulate adaptive and innate immunity for addressing the limitations of conventional ...